A tail plateau was found in the survival curves of patients with advanced, EGFR-mutated and ALK-rearranged NSCLC, but most were on treatment, especially with EGFR-mutated NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.